0000950170-24-007962.txt : 20240126 0000950170-24-007962.hdr.sgml : 20240126 20240126163007 ACCESSION NUMBER: 0000950170-24-007962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240124 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roche Corleen M. CENTRAL INDEX KEY: 0001857905 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41925 FILM NUMBER: 24568312 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE, SUITE 300 STREET 2: C/O IMMUNOME, INC. CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CG Oncology, Inc. CENTRAL INDEX KEY: 0001991792 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371611499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 SPECTRUM CENTER DRIVE STREET 2: SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 419-6203 MAIL ADDRESS: STREET 1: 400 SPECTRUM CENTER DRIVE STREET 2: SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 4 1 ownership.xml 4 X0508 4 2024-01-24 0001991792 CG Oncology, Inc. CGON 0001857905 Roche Corleen M. C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618 false true false false CFO & Secretary false Stock Option 19.00 2024-01-24 4 A false 492920 0 A 2034-01-10 Common Stock 492920 492920 D The stock option vests as to 25% of the underlying shares on January 16, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter. /s/ Corleen Roche 2024-01-26